332 related articles for article (PubMed ID: 26008147)
1. Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.
Dos Santos P; Panero J; Palau Nagore V; Stanganelli C; Bezares RF; Slavutsky I
Tumour Biol; 2015 Nov; 36(11):8317-24. PubMed ID: 26008147
[TBL] [Abstract][Full Text] [Related]
2. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
3. Increased genomic alteration complexity and telomere shortening in B-CLL cells resistant to radiation-induced apoptosis.
Salin H; Ricoul M; Morat L; Sabatier L
Cytogenet Genome Res; 2008; 122(3-4):343-9. PubMed ID: 19188704
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia.
Dos Santos PC; Panero J; Stanganelli C; Palau Nagore V; Stella F; Bezares R; Slavutsky I
PLoS One; 2017; 12(6):e0179883. PubMed ID: 28666010
[TBL] [Abstract][Full Text] [Related]
5. Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia.
Jebaraj BMC; Tausch E; Landau DA; Bahlo J; Robrecht S; Taylor-Weiner AN; Bloehdorn J; Scheffold A; Mertens D; Böttcher S; Kneba M; Jäger U; Zenz T; Wenger MK; Fingerle-Rowson G; Wendtner C; Fink AM; Wu CJ; Eichhorst B; Fischer K; Hallek M; Döhner H; Stilgenbauer S
Leukemia; 2019 Sep; 33(9):2183-2194. PubMed ID: 30911113
[TBL] [Abstract][Full Text] [Related]
6. Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome.
Steinbrecher D; Jebaraj BMC; Schneider C; Edelmann J; Cymbalista F; Leblond V; Delmer A; Ibach S; Tausch E; Scheffold A; Bloehdorn J; Hallek M; Dreger P; Döhner H; Stilgenbauer S
Leuk Lymphoma; 2018 Jul; 59(7):1614-1623. PubMed ID: 29063805
[TBL] [Abstract][Full Text] [Related]
7. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
8. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
9. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
10. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.
Lin TT; Letsolo BT; Jones RE; Rowson J; Pratt G; Hewamana S; Fegan C; Pepper C; Baird DM
Blood; 2010 Sep; 116(11):1899-907. PubMed ID: 20538793
[TBL] [Abstract][Full Text] [Related]
11. Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia.
Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
Onkologie; 2001 Feb; 24(1):60-5. PubMed ID: 11441283
[TBL] [Abstract][Full Text] [Related]
12. Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.
González-Gascón Y Marín I; Hernández-Sanchez M; Rodríguez-Vicente AE; Puiggros A; Collado R; Luño E; González T; Ruiz-Xivillé N; Ortega M; Gimeno E; Muñoz C; Infante MS; Delgado J; Vargas MT; González M; Bosch F; Espinet B; Hernández-Rivas JM; Hernández JÁ;
Leuk Lymphoma; 2018 Mar; 59(3):633-642. PubMed ID: 28728469
[TBL] [Abstract][Full Text] [Related]
13. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis.
Döhner H; Stilgenbauer S; James MR; Benner A; Weilguni T; Bentz M; Fischer K; Hunstein W; Lichter P
Blood; 1997 Apr; 89(7):2516-22. PubMed ID: 9116297
[TBL] [Abstract][Full Text] [Related]
14. Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population.
Song DY; Kim JA; Jeong D; Yun J; Kim SM; Lim K; Park SN; Im K; Choi S; Yoon SS; Lee DS
PLoS One; 2019; 14(7):e0220177. PubMed ID: 31335885
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
16. Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.
Hoxha M; Fabris S; Agnelli L; Bollati V; Cutrona G; Matis S; Recchia AG; Gentile M; Cortelezzi A; Morabito F; Bertazzi PA; Ferrarini M; Neri A
Genes Chromosomes Cancer; 2014 Jul; 53(7):612-21. PubMed ID: 24706380
[TBL] [Abstract][Full Text] [Related]
17. Telomere length in mantle cell lymphoma.
Jebaraj BM; Kienle D; Lechel A; Mertens D; Heuberger M; Ott G; Rosenwald A; Barth TF; Möller P; Zenz T; Döhner H; Stilgenbauer S
Blood; 2013 Feb; 121(7):1184-7. PubMed ID: 23243283
[TBL] [Abstract][Full Text] [Related]
18. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis.
Athanasiadou A; Stamatopoulos K; Tsompanakou A; Gaitatzi M; Kalogiannidis P; Anagnostopoulos A; Fassas A; Tsezou A
Cancer Genet Cytogenet; 2006 Jul; 168(2):109-19. PubMed ID: 16843100
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
20. [Detection of genomic abnormalities among 105 patients with chronic lymphocytic leukemia using fluorescence in situ hybridization].
Wang H; Xu H; Chen Z; Lou J; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):357-360. PubMed ID: 28604954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
